Stimotimagene copolymerplasmid

N/A

Report date: 2024/09/19 15:13:40

Base Information

Drug NameStimotimagene copolymerplasmid
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsPenile NeoplasmsVulvar NeoplasmsUterine Cervical Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGene Surgery LLC
China Registration ClassN/A

Develop Information

Active CompaniesGene Surgery LLC
Inactive CompaniesN/A
Active IndicationsPenile NeoplasmsVulvar NeoplasmsUterine Cervical Neoplasms +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A